NASDAQ: REPL
Replimune Group Inc Stock Ownership - Who owns Replimune Group?

Insider buying vs selling

Have Replimune Group Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kapil DhingraDirector2025-12-093,169$1.75
$5.55kBuy
Kapil DhingraDirector2025-12-093,169$10.40
$32.96kSell
Sushil PatelChief Executive Officer2025-12-0210,000$11.13
$111.30kSell
Konstantinos XynosChief Medical Officer2025-11-177,248$9.10
$65.96kSell
Christopher SarchiChief Commercial Officer2025-11-175,208$9.10
$47.39kSell
Emily Luisa HillChief Financial Officer2025-08-159,154$5.37
$49.16kSell
Emily Luisa HillChief Financial Officer2025-05-202,535$8.05
$20.41kSell
Christopher SarchiChief Commercial Officer2025-05-203,749$8.05
$30.18kSell
Sushil PatelChief Executive Officer2025-05-2025,105$8.06
$202.35kSell
Andrew SchwendenmanChief Accounting Officer2025-05-203,287$8.05
$26.46kSell

1 of 2

REPL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when REPL insiders and whales buy or sell their stock.

REPL Shareholders

What type of owners hold Replimune Group Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP12.25%10,116,095$80.63MInsider
Omega Fund IV LP11.43%9,436,760$75.21MInsider
Blackrock Inc7.35%6,069,633$48.37MInstitution
Hugo Alexander Slootweg5.72%4,721,449$37.63MInsider
Forbion Capital Fund III Cooperatief Ua5.72%4,721,449$37.63MInsider
Vanguard Group Inc4.57%3,776,198$30.10MInstitution
State Street Corp4.47%3,693,107$29.43MInstitution
Bain Capital Life Sciences Investors LLC3.44%2,838,968$22.63MInsider
Atlas Venture Fund X LP3.01%2,486,296$19.82MInsider
Erste Asset Management Gmbh2.57%2,120,000$16.90MInstitution

1 of 3

REPL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
REPL35.86%50.87%Net SellingNet Selling
ANRO33.32%21.66%
PRME36.45%63.51%Net Buying
ANNX37.51%23.17%Net BuyingNet Buying
NMRA16.77%83.23%Net Buying

Replimune Group Stock Ownership FAQ

Who owns Replimune Group?

Replimune Group (NASDAQ: REPL) is owned by 35.86% institutional shareholders, 50.87% Replimune Group insiders, and 13.27% retail investors. Baker Bros Advisors LP is the largest individual Replimune Group shareholder, owning 10.12M shares representing 12.25% of the company. Baker Bros Advisors LP's Replimune Group shares are currently valued at $73.44M.

If you're new to stock investing, here's how to buy Replimune Group stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.